• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.09%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    7.88 Down 0.10(1.25%) 9:36AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.98
    Open:N/A
    Bid:7.60 x 900
    Ask:8.09 x 800
    1y Target Est:20.33
    Beta:6.83
    Next Earnings Date: 5-Aug-15KERX Earnings announcement
    Day's Range:7.76 - 7.98
    52wk Range:7.29 - 18.48
    Volume:15,469
    Avg Vol (3m):1,751,060
    Market Cap:816.34M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 1.25%816.34M
    BAXDown 0.54%21.67B
    SHPGDown 0.09%52.47B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):413.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.92
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-0.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback